The decision is a major win for MSD, which will now have the upper hand on BMS and its rival treatment Opdivo, which has been put forward for restricted use through the new Cancer Drugs Fund (CDF ...

A study published in Nature Medicine looks at the health risks and benefits linked to GLP-1 receptor agonists. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University ...

America's pharmaceutical founding fathers Meanwhile ... whilst “American” Merck (now Merck & Co. in the US or Merck Sharp & Dohme (MSD) elsewhere) was compulsorily split off from its Germany ...

The company works in collaboration with Merck Sharp and Dohme, LTS Lohmann Therapie-Systeme AG and other pharmaceutical companies to develop novel delivery systems for advancing its pipeline drug ...

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...

Avadel Pharmaceuticals appointed Sev Melkonian as VP of patient services, distribution and reimbursement. Experity appointed ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.